RevCycleAI Brief
Published researchAI-powered revenue cycle orchestration platform that identifies revenue risk and automates action across denials, A/R, payer friction and other high-friction workflows.
✦ Ask RevCycleAI about Adonis
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →Key findings
Research highlightsAdonis becomes more defensible if its closed-loop data improves payer-specific action over time. The key diligence question is whether orchestration produces durable enterprise results beyond denial-worklist optimization.
ApolloMD reports a 67% reduction in denials using Adonis
Allied Digestive Health reports 4.5x first-year ROI with Adonis
Fox Valley Orthopedics reports nearly $200,000 in denials caught and recouped
RevCycleAI Intelligence Scores
MethodologyMarket Matrix: Leader · Impact 80 · Capability 81
Funding & transaction history
5 trackedAI orchestration platform for revenue cycle operations. 4x revenue growth in 2025, NRR above 130%. Round context: passage of the One Big Beautiful Bill reshaped Medicaid and ACA subsidies, increasing uninsured/self-pay volumes and adding reimbursement complexity — creating direct tailwind for AI-assisted RCM platforms.
Adonis raised $31 million in Series B financing led by Point72 Private Investments, bringing disclosed funding at that point to $54 million.
AI platform for accurate medical billing and timely payments. Automates billing workflows and identifies revenue leakage across the claims lifecycle.
Adonis raised a $17.3 million Series A led by General Catalyst, preceding its 2024 Series B.
Adonis raised $5.6 million in seed funding led by Bling Capital before its $17.3 million Series A. The exact day is not stated on the currently published company resource, so RevCycleAI records the month and flags the event date as approximate.